Trial
NCT05847920
Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Collaborators
—
Condition
Primary IgA Nephropathy
Intervention
SHR-2010 Injection
Why stopped
Based on the adjustment of the R \& D strategy, the sponsor decides to terminate the research.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-05